---
title: "CanSinoBIO Showcases Vaccine Innovation at World Government Summit 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275321399.md"
description: "CanSino Biologics Inc. showcased its vaccine innovations at the World Government Summit 2026 in Dubai, where CEO Dr. Xuefeng Yu participated in a panel discussion. The company emphasized its commitment to addressing global health challenges through innovation and partnerships, particularly in Indonesia, Saudi Arabia, and Malaysia. This marks CanSinoBIO's second consecutive year as the sole global vaccine maker invited to the summit."
datetime: "2026-02-09T13:04:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275321399.md)
  - [en](https://longbridge.com/en/news/275321399.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275321399.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275321399.md) | [繁體中文](https://longbridge.com/zh-HK/news/275321399.md)


# CanSinoBIO Showcases Vaccine Innovation at World Government Summit 2026

CanSino Biologics Inc. participated in the World Government Summit 2026 (WGS 2026) held in Dubai, UAE from February 3 to 5. As the sole global vaccine maker invited for the second consecutive year, Chairman and CEO Dr. Xuefeng Yu took part in a panel discussion at the “New Silk Road Forum,” where he highlighted the company’s efforts to address global public health challenges through innovation and international cooperation. The event also showcased CanSinoBIO’s advancements in vaccine research, development, and global partnerships, particularly in regions such as Indonesia, Saudi Arabia, and Malaysia. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cansino Biologics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN83463) on February 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CANSINOBIO (06185.HK)](https://longbridge.com/en/quote/06185.HK.md)

## Related News & Research

- [CanSino Biologics Wins PIC/S GMP Nod for Key Conjugate Vaccines](https://longbridge.com/en/news/277909067.md)
- [CanSino Biologics forecasts significant non-recurring profit for 2025](https://longbridge.com/en/news/273811975.md)
- [Indonesia Plans to Ban High-Risk Digital Platforms for Children Under 16](https://longbridge.com/en/news/278082913.md)
- [RFK Jr has 'unreviewable' authority to reshape vaccine policy, DOJ lawyer tells judge](https://longbridge.com/en/news/277824261.md)
- [CanSino Biologics Inc. nimmt am World Governments Summit 2026 in Dubai teil](https://longbridge.com/en/news/274972790.md)